Consistent with the clinical observations, KLHL39 suppresses colon cancer migration, invasion, and metastasis, and these tumor-suppressive effects are all mediated through a PML- and DAPK-dependent manner. The gene discussed is DAPK1; the disease is malignant colon neoplasm.